Murali Janakiram

Assistant Professor, Medicine - Hematology, Oncology, Transplant

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

Dive into the research topics where Murali Janakiram is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5 Active

MT2020-23: A Phase I, Open-Label, Multicenter Study of FT538 as Monotherapy in Relapsed/Refractory Acute Myelogenous Leukemia and in Combination with Monoclonal Antibodies in Relapsed/Refractory Multiple Myeloma
Janakiram, M.
Fate Therapeutics, Inc.
6/1/20 → 5/31/25
Project: Research project
A PHASE 1, OPEN-LABEL, MULTI-CENTER, DOSE ESCALATION AND DOSEEXPANSION STUDY OF NKTR-255 AS A SINGLE AGENT IN RELAPSED OR REFRACTORYHEMATOLOGICAL MALIGNANCIES AND IN COMBINATION WITH DARATUMUMAB AS A SALVAGEREGIMEN FOR MULTIPLE MYELOMA
Janakiram, M.
NEKTAR THERAPEUTICS
12/2/19 → 12/31/24
Project: Research project
A Phase 1/2a Open-label Study to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 (formerly TEV-48573) Administered Intravenously as a Single Agent in Patients With Refractory Multiple Myeloma
Janakiram, M.
Takeda Cambridge Ltd.
8/14/19 → 8/30/24
Project: Research project
Phase I/II Study of Ixazomib and Romidepsin in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL): Big Ten Cancer Research Consortium BTCRC-HEM15-028
Janakiram, M.
BIG TEN CANCER RESEARCH CONSORTIUM
9/1/18 → 8/30/22
Project: Research project
Open label Dose Escalation Trial of an Adaptive Natural
Janakiram, M.
Fate Therapeutics, Inc.
10/1/16 → 4/24/21
Project: Research project

50 Article
6 Review article
1 Chapter
1 Letter

Cardiovascular Complications and Their Association With Mortality in Patients With Thrombotic Thrombocytopenic Purpura
Balasubramaniyam, N., Yandrapalli, S., Kolte, D., Pemmasani, G., Janakiram, M. & Frishman, W. H., Feb 2021, In: American Journal of Medicine. 134, 2, p. e89-e97
Research output: Contribution to journal › Article › peer-review
Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
Abbasi, A., Peeke, S., Shah, N., Mustafa, J., Khatun, F., Lombardo, A., Abreu, M., Elkind, R., Fehn, K., de Castro, A., Wang, Y., Derman, O., Nelson, R., Uehlinger, J., Gritsman, K., Sica, R. A., Kornblum, N., Mantzaris, I., Shastri, A., Janakiram, M. & 4 others, Goldfinger, M., Verma, A., Braunschweig, I. & Bachier-Rodriguez, L., Jan 3 2020, In: Journal of hematology & oncology. 13, 1, 1 p.
Research output: Contribution to journal › Article › peer-review

Open Access
7 Scopus citations
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
The CAR T-cell Consortium, Jul 2020, In: Biology of Blood and Marrow Transplantation. 26, 7, p. 1239-1246 8 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
18 Scopus citations
Chimeric antigen receptor T-cell therapy for HIV-associated diffuse large B-cell lymphoma: case report and management recommendations
Allred, J., Bharucha, K., Özütemiz, C., He, F., Janakiram, M., Maakaron, J., Carrier, C., Grzywacz, B. & Bachanova, V., 2020, (Accepted/In press) In: Bone marrow transplantation.
Research output: Contribution to journal › Letter › peer-review
Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: A systematic review and meta-analysis
Goyal, A., O'Leary, D. H., Goyal, K., Patel, K., Pearson, D. R. & Janakiram, M., 2020, (Accepted/In press) In: Journal of the American Academy of Dermatology.
Research output: Contribution to journal › Article › peer-review